In The News

AtriCure gets outside help with innovation

January 3, 2013  |  AtriCure

Business Courier by James Ritchie, Staff Reporter

AtriCure Inc. will work with Cleveland-based NineSigma Inc. to find new approaches to technical problems.

The cooperation is part of the new Ohio Third Frontier Open Innovation Incentive Program.

In August, NineSigma was selected by the state of Ohio to help catalyze the growth of middle-market companies, with revenues between $10 million and $1 billion, by accelerating their adoption of open innovation. The state funds part of the costs of engaging the open innovation company.

West Chester-based AtriCure makes medical devices used to treat atrial fibrillation.

“We look forward to beginning our work with the team at AtriCure to help them find best-in-class partners and technologies globally that will advance their cardiac surgical solutions and ability to treat this pervasive condition,” Andy Zynga, CEO of NineSigma, said in a news release.

NineSigma provides open innovation services to help companies to “solve immediate challenges, integrate new knowledge, fill product pipelines, and stay ahead of the competition,” according to the release.